The checkpoint generated between the PD-1 (programmed death protein-1) expressed by immune-stimulated peripheral immunocytes and its ligand PD-L1 expressed by the tumor target cells is expected to engage the antitumor cytotoxic killer cell and its tumor target in a manner that prevents cytotoxicity [28]. This evidence concerns the gene CD274 and neoplasm.